AMETEK, Inc. $AME Holdings Raised by Allianz Asset Management GmbH

Allianz Asset Management GmbH grew its stake in shares of AMETEK, Inc. (NYSE:AME) by 60.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 210,064 shares of the technology company’s stock after acquiring an additional 79,277 shares during the period. Allianz Asset Management GmbH owned 0.09% of AMETEK worth $39,492,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in AMETEK in the 2nd quarter worth about $25,000. TruNorth Capital Management LLC acquired a new position in AMETEK in the third quarter worth approximately $31,000. NewSquare Capital LLC raised its position in AMETEK by 129.7% during the second quarter. NewSquare Capital LLC now owns 170 shares of the technology company’s stock valued at $31,000 after acquiring an additional 96 shares in the last quarter. SouthState Corp raised its position in AMETEK by 47.4% during the second quarter. SouthState Corp now owns 202 shares of the technology company’s stock valued at $37,000 after acquiring an additional 65 shares in the last quarter. Finally, Grey Fox Wealth Advisors LLC acquired a new stake in AMETEK in the third quarter valued at approximately $39,000. 87.43% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AME has been the topic of a number of recent research reports. Mizuho set a $235.00 price target on shares of AMETEK in a report on Wednesday. Wall Street Zen upgraded AMETEK from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. TD Cowen reiterated a “buy” rating on shares of AMETEK in a research note on Tuesday. Deutsche Bank Aktiengesellschaft began coverage on AMETEK in a research note on Wednesday, January 21st. They issued a “buy” rating and a $271.00 price objective on the stock. Finally, Morgan Stanley upped their target price on AMETEK from $198.00 to $215.00 and gave the stock an “equal weight” rating in a research report on Monday, January 12th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $243.00.

AMETEK Price Performance

Shares of NYSE:AME opened at $229.63 on Friday. The company has a market cap of $52.86 billion, a price-to-earnings ratio of 35.88, a PEG ratio of 3.09 and a beta of 1.03. The business has a 50 day moving average price of $210.31 and a 200 day moving average price of $195.30. The company has a quick ratio of 0.72, a current ratio of 1.06 and a debt-to-equity ratio of 0.10. AMETEK, Inc. has a twelve month low of $145.02 and a twelve month high of $234.56.

AMETEK (NYSE:AME) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.07. The company had revenue of $2 billion during the quarter, compared to analyst estimates of $1.94 billion. AMETEK had a return on equity of 16.55% and a net margin of 20.00%.The company’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.87 earnings per share. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. Research analysts predict that AMETEK, Inc. will post 7.15 earnings per share for the current year.

Key Stories Impacting AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Q4 earnings beat and revenue growth — AMETEK reported Q4 results that topped estimates, with EPS and revenues up year-over-year and broad strength across both operating segments. AMETEK Q4 Earnings Surpass Expectations, Revenues Rise Y/Y
• Positive Sentiment: Record 2025 and earnings-call highlights — Management called out a record year (2025) and provided color on drivers, supporting the narrative of durable end-market demand and execution. AMETEK (AME) Earnings Call Highlights Record Year
• Positive Sentiment: LKC deal and strategic M&A tailwinds — Coverage notes the LKC acquisition and other niche-market deals as contributors to 2025 results and future addressable-market expansion. How Record 2025 Results and LKC Deal Will Impact AMETEK (AME) Investors
• Positive Sentiment: Analyst upgrades/target increases — KeyCorp raised its price target to $260 (overweight) and DA Davidson reaffirmed a buy with a $240 target, signaling dealer confidence that upside remains from current levels. Benzinga
• Positive Sentiment: New distribution partnership — Transcat will distribute and calibrate AMETEK’s programmable power supplies across the Americas, widening go-to-market reach for a product line that supports industrial and test customers. Transcat to distribute, calibrate Ametek Programmable Power supplies in Americas
• Neutral Sentiment: Growth opportunities vs. premium valuation — Coverage highlights AMETEK’s expansion into ophthalmic technologies as a growth vector but notes the stock is trading at a premium multiple, which could limit upside without continued execution. AMETEK Eyes Growth In Ophthalmic Tech While Valuation Stays Premium
• Neutral Sentiment: Acquisitions offset margin pressure — Analysis says acquisitions and niche-market expansion helped results but also flagged margin pressure; mixed implications for near-term profitability. AME Q4 deep dive: Acquisitions and niche market expansion offset margin pressure
• Negative Sentiment: Analyst caution — Morgan Stanley maintained a Hold and a $215 price target, reflecting concerns about margin durability and valuation that could cap near-term gains. Resilient Revenue and Margin Caution Keep Ametek at Hold

Insider Activity

In other AMETEK news, insider Thomas C. Marecic sold 14,310 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $202.11, for a total value of $2,892,194.10. Following the completion of the transaction, the insider owned 42,589 shares of the company’s stock, valued at $8,607,662.79. This represents a 25.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Thomas M. Montgomery sold 6,388 shares of the firm’s stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $205.05, for a total value of $1,309,859.40. Following the completion of the sale, the vice president owned 22,116 shares of the company’s stock, valued at $4,534,885.80. This represents a 22.41% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 137,088 shares of company stock valued at $27,212,340. Insiders own 0.57% of the company’s stock.

AMETEK Profile

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.